Roche Holding AG (OTCMKTS:RHHBY) Given Average Recommendation of "Hold" by Brokerages

Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) has been given a consensus recommendation of "Hold" by the six brokerages that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has issued a strong buy rating on the company.

A number of equities research analysts recently commented on the stock. Morgan Stanley assumed coverage on shares of Roche in a report on Wednesday. They set an "equal weight" rating for the company. Sanford C. Bernstein upgraded shares of Roche to a "strong-buy" rating in a report on Thursday, January 30th.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. Hancock Whitney Corp raised its holdings in Roche by 6.8% in the 4th quarter. Hancock Whitney Corp now owns 23,516 shares of the company's stock worth $820,000 after purchasing an additional 1,496 shares in the last quarter. HighPoint Advisor Group LLC raised its holdings in Roche by 2.8% in the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock worth $387,000 after purchasing an additional 304 shares in the last quarter. SVB Wealth LLC bought a new position in Roche in the 4th quarter worth $555,000. Altrius Capital Management Inc raised its holdings in Roche by 0.3% in the 4th quarter. Altrius Capital Management Inc now owns 183,448 shares of the company's stock worth $6,399,000 after purchasing an additional 603 shares in the last quarter. Finally, Verity Asset Management Inc. increased its stake in shares of Roche by 26.8% in the 4th quarter. Verity Asset Management Inc. now owns 8,036 shares of the company's stock worth $280,000 after acquiring an additional 1,697 shares in the last quarter.

Roche Stock Down 0.6 %

OTCMKTS:RHHBY traded down $0.24 during midday trading on Wednesday, reaching $41.05. 1,158,538 shares of the stock traded hands, compared to its average volume of 1,758,382. The company has a fifty day moving average of $37.04 and a 200 day moving average of $38.34. Roche has a 12 month low of $29.20 and a 12 month high of $42.43. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.